Neutralization of Shiga toxins Stx1, Stx2c, and Stx2e by recombinant bacteria expressing mimics of globotriose and globotetraose
about
Designer probiotics: Development and applications in gastrointestinal healthApproaches to treatment of emerging Shiga toxin-producing Escherichia coli infections highlighting the O104:H4 serotypeRational design of improved pharmabioticsPurification and characterization of Shiga toxin 2f, an immunologically unrelated subtype of Shiga toxin 2A new family of potent AB(5) cytotoxins produced by Shiga toxigenic Escherichia coli.Treatment and prevention of enterohemorrhagic Escherichia coli infection and hemolytic uremic syndrome.Hemolytic uremic syndrome: pathogenesis and update of interventions.Recent progress of Shiga toxin neutralizer for treatment of infections by Shiga toxin-producing Escherichia coli.Treatment of enterohemorrhagic Escherichia coli (EHEC) infection and hemolytic uremic syndrome (HUS).Therapeutic use of a receptor mimic probiotic reduces intestinal Shiga toxin levels in a piglet model of hemolytic uremic syndrome.Characterization of a human monoclonal antibody against Shiga toxin 2 expressed in Chinese hamster ovary cells.Bioengineered bugs expressing oligosaccharide receptor mimics: toxin-binding probiotics for treatment and prevention of enteric infectionsShiga toxin subtypes display dramatic differences in potencyDevelopment of monoclonal antibodies and immunoassays for sensitive and specific detection of Shiga toxin Stx2f.Stx2-specific human monoclonal antibodies protect mice against lethal infection with Escherichia coli expressing Stx2 variantsPrebiotic galactooligosaccharides reduce adherence of enteropathogenic Escherichia coli to tissue culture cellsNew Stx2e Monoclonal Antibodies for Immunological Detection and Distinction of Stx2 Subtypes.Probiotics and prebiotics in human health.New Monoclonal Antibodies against a Novel Subtype of Shiga Toxin 1 Produced by Enterobacter cloacae and Their Use in Analysis of Human Serum.Targeting ricin to the ribosome.Probiotics and gastrointestinal infections.Facing glycosphingolipid-Shiga toxin interaction: dire straits for endothelial cells of the human vasculature.Glycans-by-design: engineering bacteria for the biosynthesis of complex glycans and glycoconjugates.Functional characterization of Gne (UDP-N-acetylglucosamine-4-epimerase), Wzz (chain length determinant), and Wzy (O-antigen polymerase) of Yersinia enterocolitica serotype O:8Functional expression of enterobacterial O-polysaccharide biosynthesis enzymes in Bacillus subtilis.The O-antigen gene cluster of Escherichia coli O55:H7 and identification of a new UDP-GlcNAc C4 epimerase gene.Lactobacillus plantarum isolated from kefir protects vero cells from cytotoxicity by type-II shiga toxin from Escherichia coli O157:H7.Strategies to avoid Shiga toxin effects.Differential carbohydrate epitope recognition of globotriaosyl ceramide by verotoxins and a monoclonal antibody.
P2860
Q26795388-A4A3ABE1-C866-4A36-9137-C5BB4CCD37F7Q28087714-1E96BBDB-7E34-43D1-9E45-7EFA1DF99464Q28258559-51829ABD-C0B1-4B78-A313-536D50AAC449Q28488900-EC4AD577-FA28-46AB-B23B-DB8197E2F85CQ30940276-FE7F9019-7747-4209-B901-E8C576205044Q33376138-A3E35501-4965-40A9-8657-E3439C8BBF87Q33385809-26FC9873-1D2D-484A-8693-EBEFE7F165ECQ33395662-17E08E59-77C0-4C53-BE45-F3BBFF11520CQ33399468-B1FCD093-30E0-4563-84F6-F0C76CE21BF4Q33415691-B1C0E2F4-1940-4092-BFF3-316BE2786509Q33883354-717C05A8-F9F6-4FBA-B653-C2372B407A7AQ34518407-E72E54D6-8A25-461C-8249-4895D3977953Q34739913-9D8DF97F-8FC1-4C27-96BA-0B1894B3530BQ34999780-F7B1FF81-CCAC-436D-811B-8218526A9806Q35012815-1AECDDA6-73B4-4EBC-AB5A-EDE466D7411CQ35220308-B77BB919-4EF8-45D8-87C3-B78C8CAEFC69Q35698625-35E99CFD-AB7B-4D1A-BC76-E723BC14A12AQ36402193-C05935BF-547C-4F6B-8743-3B3808CE777BQ36891324-B598E203-4FDF-4795-8672-BA536F9275B4Q36901746-CF6313CB-6D44-4D22-9812-9F75B23C16DBQ37111223-CC7D7C9F-94CF-428B-9D3B-FB57D774C6AFQ38024274-122D5A4F-0D3D-4002-A88D-A5946F60F743Q38086151-21E79EC2-71F6-4736-BA28-D46FF4CB2861Q38287346-B5E20AD3-0DD3-4875-B0AC-96F5BF9CD7DDQ39648887-9DCE638D-ED78-4698-84F9-05E8836DE2CFQ39679036-2C71367C-115F-4D7D-8ABD-B1FC8885086CQ42284960-16D83AB5-7DE2-4F72-BB66-03CB00C34C34Q42591654-47CCB43D-6833-47E8-A555-86CAD27A12DCQ44724601-384D53BC-14B8-4713-A42C-7C736B7AF82B
P2860
Neutralization of Shiga toxins Stx1, Stx2c, and Stx2e by recombinant bacteria expressing mimics of globotriose and globotetraose
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Neutralization of Shiga toxins ...... globotriose and globotetraose
@ast
Neutralization of Shiga toxins ...... globotriose and globotetraose
@en
Neutralization of Shiga toxins ...... globotriose and globotetraose
@nl
type
label
Neutralization of Shiga toxins ...... globotriose and globotetraose
@ast
Neutralization of Shiga toxins ...... globotriose and globotetraose
@en
Neutralization of Shiga toxins ...... globotriose and globotetraose
@nl
prefLabel
Neutralization of Shiga toxins ...... globotriose and globotetraose
@ast
Neutralization of Shiga toxins ...... globotriose and globotetraose
@en
Neutralization of Shiga toxins ...... globotriose and globotetraose
@nl
P2860
P1476
Neutralization of Shiga toxins ...... globotriose and globotetraose
@en
P2093
P2860
P304
P356
10.1128/IAI.69.3.1967-1970.2001
P407
P50
P577
2001-03-01T00:00:00Z